Global health R&D benefits rich countries too, study argues
As the US reduces its funding for global health research, a new study highlights an important trend: much of this money remains within wealthy countries. The research suggests that investments often lead to inventions that are subsequently repurposed for people in wealthy, donor nations.
During Donald Trump’s second administration, significant changes were made to US global health initiatives. Notably, the US Agency for International Development (USAID) was closed. Additionally, efforts were made to halt overseas sub-awards from the country’s National Institutes of Health (NIH).
These shifts have raised concerns about the future of global health research funding and its impact on low- and middle-income countries.
https://sciencebusiness.net/news/r-d-funding/drug-development/global-health-rd-benefits-rich-countries-too-study-argues
You may also like
Leave a Reply